These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 29718751

  • 1. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
    Oldenburg CE, Venkatesh Prajna N, Krishnan T, Rajaraman R, Srinivasan M, Ray KJ, O'Brien KS, Glymour MM, Porco TC, Acharya NR, Rose-Nussbaumer J, Lietman TM.
    Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV, Krishnan T, Rajaraman R, Patel S, Srinivasan M, Das M, Ray KJ, O'Brien KS, Oldenburg CE, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial II Group.
    JAMA Ophthalmol; 2016 Dec 01; 134(12):1365-1372. PubMed ID: 27787540
    [Abstract] [Full Text] [Related]

  • 4. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    JAMA Ophthalmol; 2013 Apr 01; 131(4):422-9. PubMed ID: 23710492
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
    Rose-Nussbaumer J, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, Oldenburg CE, O'Brien KS, Ray KJ, Porco TC, McLeod SD, Acharya NR, Keenan JD, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Br J Ophthalmol; 2016 Jul 01; 100(7):929-932. PubMed ID: 26531051
    [Abstract] [Full Text] [Related]

  • 6. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR.
    Arch Ophthalmol; 2010 Jun 01; 128(6):672-8. PubMed ID: 20547942
    [Abstract] [Full Text] [Related]

  • 7. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    Rose-Nussbaumer J, Prajna NV, Krishnan KT, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, Oldenburg CE, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Lietman TM, Acharya NR, Keenan JD, Mycotic Ulcer Treatment Trial I Group.
    JAMA Ophthalmol; 2015 Jun 01; 133(6):642-6. PubMed ID: 25764482
    [Abstract] [Full Text] [Related]

  • 8. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R, Gupta D, Goyal J, Kaur R.
    Clin Exp Ophthalmol; 2011 Jul 01; 39(5):434-40. PubMed ID: 21105974
    [Abstract] [Full Text] [Related]

  • 9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Ophthalmology; 2014 Aug 01; 121(8):1495-500.e1. PubMed ID: 24746358
    [Abstract] [Full Text] [Related]

  • 10. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
    Sharma S, Das S, Virdi A, Fernandes M, Sahu SK, Kumar Koday N, Ali MH, Garg P, Motukupally SR.
    Br J Ophthalmol; 2015 Sep 01; 99(9):1190-5. PubMed ID: 25740805
    [Abstract] [Full Text] [Related]

  • 11. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
    Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM.
    Invest Ophthalmol Vis Sci; 2013 Jun 14; 54(6):4167-73. PubMed ID: 23702779
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo.
    Cho J, Prajna NV, Lalitha P, Rajaraman R, Krishnan T, Lin YB, Ray KJ, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group.
    Am J Ophthalmol; 2018 Aug 14; 192():142-145. PubMed ID: 29758184
    [Abstract] [Full Text] [Related]

  • 13. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
    Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Austin A, Pickel J, Porco T, Lietman T, Rose-Nussbaumer J.
    Ophthalmology; 2019 Aug 14; 126(8):1084-1089. PubMed ID: 30904540
    [Abstract] [Full Text] [Related]

  • 14. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ, Yadav R, Sanyam SD, Chaudhary P, Roshan A, Singh SK, Singh SK, Mishra SK, Arunga S, Hu VH, Macleod D, Leck A, Burton MJ.
    Ophthalmology; 2022 May 14; 129(5):530-541. PubMed ID: 34896126
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
    Sharma N, Chacko J, Velpandian T, Titiyal JS, Sinha R, Satpathy G, Tandon R, Vajpayee RB.
    Ophthalmology; 2013 Apr 14; 120(4):677-81. PubMed ID: 23246119
    [Abstract] [Full Text] [Related]

  • 16. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
    Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Das M, Ray KJ, Oldenburg CE, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group.
    JAMA Ophthalmol; 2017 Sep 01; 135(9):987-991. PubMed ID: 28817744
    [Abstract] [Full Text] [Related]

  • 17. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    Pickel J, Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Porco TC, Redd T, Lietman TM, Rose-Nussbaumer J.
    Am J Ophthalmol; 2020 Jul 01; 215():1-7. PubMed ID: 32171765
    [Abstract] [Full Text] [Related]

  • 18. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
    Prajna NV, Lalitha P, Rajaraman R, Krishnan T, Raghavan A, Srinivasan M, O'Brien KS, Zegans M, McLeod SD, Acharya NR, Keenan JD, Lietman TM, Rose-Nussbaumer J, Mycotic Ulcer Treatment Trial Group.
    JAMA Ophthalmol; 2016 Jun 01; 134(6):693-6. PubMed ID: 27054515
    [Abstract] [Full Text] [Related]

  • 19. Update on the Management of Infectious Keratitis.
    Austin A, Lietman T, Rose-Nussbaumer J.
    Ophthalmology; 2017 Nov 01; 124(11):1678-1689. PubMed ID: 28942073
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
    Sharma N, Singhal D, Maharana PK, Sinha R, Agarwal T, Upadhyay AD, Velpandian T, Satpathy G, Titiyal JS.
    Cornea; 2017 Dec 01; 36(12):1521-1527. PubMed ID: 28902012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.